Skip to main content
Signal8

PERLMAN ANDREW J

SEC insider (Form 3/4/5 filer). CIK 0001201617. Director at Arcus Biosciences, Inc. (RCUS). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in HAYWARD, CA.

Companies PERLMAN ANDREW J has filed insider reports for

  • Arcus Biosciences, Inc. (RCUS): Director
PERLMAN ANDREW J profile photo

PERLMAN ANDREW J

CIK: 0001201617

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 11, 2026
    Award
    Direct
    5.7K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 10, 2025
    Award
    Direct
    13.3K shares-

1-2 of 2